×
Phreesia Net Cash Flow 2019-2025 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Phreesia net cash flow from 2019 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
View More
Phreesia Net Cash Flow 2019-2025 | PHR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Phreesia net cash flow from 2019 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$48B
Doximity (DOCS)
$12.7B
Tempus AI (TEM)
$12.7B
Hims & Hers Health (HIMS)
$9.9B
IRhythm Technologies (IRTC)
$5.5B
Hinge Health (HNGE)
$4.5B
Heartflow (HTFL)
$2.8B
Inspire Medical Systems (INSP)
$2.7B
Privia Health (PRVA)
$2.7B
Enovis (ENOV)
$1.8B
10x Genomics (TXG)
$1.7B
Omnicell (OMCL)
$1.5B
Schrodinger (SDGR)
$1.5B
Azenta (AZTA)
$1.4B
Clover Health Investments (CLOV)
$1.4B
Claritev (CTEV)
$1.2B
Evolent Health (EVH)
$1.1B
Fulgent Genetics (FLGT)
$662M
Zepp Health (ZEPP)
$542M
Veradigm (MDRX)
$535M
Standard BioTools (LAB)
$489M
Talkspace (TALK)
$454M
Butterfly Network (BFLY)
$395M
Carlsmed (CARL)
$369M
TruBridge (TBRG)
$302M
Health Catalyst (HCAT)
$260M
Outset Medical (OM)
$248M
SOPHiA GENETICS SA (SOPH)
$225M
Nyxoah SA (NYXH)
$210M
KORU Medical Systems (KRMD)
$197M